(2S,5S)-1-(Tert-Butoxycarbonyl)-5-Methyl Pyrrolidine-2-Carboxylic Acid

(2S,5S)-1-(Tert-Butoxycarbonyl)-5-Methyl Pyrrolidine-2-Carboxylic Acid


    • Product Name (2S,5S)-1-(Tert-Butoxycarbonyl)-5-Methyl Pyrrolidine-2-Carboxylic Acid
    • Alias Boc-5-methyl-L-proline
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    424300

    Chemical Formula C13H23NO5
    Molar Mass 273.325 g/mol
    Physical State Solid (usually)
    Appearance White to off - white solid
    Melting Point Typically in a certain range, data may vary by source
    Solubility In Water Low solubility in water
    Solubility In Organic Solvents Soluble in some organic solvents like dichloromethane
    Chirality Has (2S,5S) - chiral configuration
    Functional Groups Tert - butoxycarbonyl group, carboxylic acid group, pyrrolidine ring
    Pka Of Carboxylic Acid Group Typical carboxylic acid pKa range applicable, exact value may vary

    As an accredited (2S,5S)-1-(Tert-Butoxycarbonyl)-5-Methyl Pyrrolidine-2-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of (2S,5S)-1-(Tert - Butoxycarbonyl)-5 - Methyl Pyrrolidine - 2 - Carboxylic Acid in sealed vial.
    Shipping (2S,5S)-1-(Tert - Butoxycarbonyl)-5 - Methyl Pyrrolidine - 2 - Carboxylic Acid is shipped in well - sealed containers, safeguarded against moisture and physical damage. Shipping adheres to strict chemical transportation regulations.
    Storage (2S,5S)-1-(tert -Butoxycarbonyl)-5 -Methyl Pyrrolidine-2 -Carboxylic Acid should be stored in a cool, dry place, away from direct sunlight and heat sources. Keep it in a tightly sealed container to prevent moisture absorption and exposure to air, which could lead to degradation. Store it separately from incompatible substances to avoid potential chemical reactions.
    Application of (2S,5S)-1-(Tert-Butoxycarbonyl)-5-Methyl Pyrrolidine-2-Carboxylic Acid

    What drives the demand for enantiopure (2S,5S)-configured proline surrogates in antiviral pipelines?

    In the construction of macrocyclic hepatitis C virus NS3/4A protease inhibitors, the (2S,5S)-5-methyl substitution pattern on the pyrrolidine ring drastically alters the torsional profile of the P2 proline residue, locking the five-membered ring into a specific envelope pucker that pre-organises the N-terminal capping group for optimal hydrogen-bonding with the catalytic serine. The N-Boc-protected compound is employed directly in solution-phase fragment couplings where the acid functionality is pre-activated without epimerisation. Activation via isobutyl chloroformate (IBCF) and N-methylmorpholine (NMM) at -20 °C to -15 °C in anhydrous tetrahydrofuran generates a mixed anhydride that reacts with a P3 amine fragment within 30–45 min. Strict anhydrous conditions are enforced; residual water above 300 ppm promotes hydrolysis of the anhydride and depresses the yield below 70%. Post-coupling, the Boc group is retained to preserve the secondary amine during subsequent oxidation or macrolactamisation steps, being removed only after ring closure with 50% trifluoroacetic acid in dichloromethane containing 2.5% triisopropylsilane as scavenger. Process monitoring relies on chiral HPLC using a Chiralpak IA column and n-hexane/ethanol/trifluoroacetic acid 0.1% mobile phase; the target (2S,5S)-diastereomer elutes at a relative retention time of 1.21 against the unwanted (2R,5R) impurity, ensuring a diastereomeric excess exceeding 99.5% before progressing to GMP step. Residual tin from any preceding Stannous chloride-mediated methyl group introduction must be quantified by ICP-MS and kept below 10 µg/g in accordance with ICH Q3D.

    The incorporation of (2S,5S)-1-(tert-butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid into the macrocyclic scaffold is not merely a matter of potency; the methyl group provides steric shielding against CYP3A4-mediated oxidation at the pyrrolidine C-5 position, as evidenced by comparative intrinsic clearance assays in human liver microsomes where the methylated analogue displays a t1/2 > 120 min versus 37 min for the des-methyl congener. When designing a downstream amidation with a P1’ acyl sulfonamide, the carboxy group is often converted to the pentafluorophenyl ester using pentafluorophenol and dicyclohexylcarbodiimide at 0 °C for 2 h, followed by filtration of dicyclohexylurea and immediate reaction with the amine component to suppress diketopiperazine formation. The entire sequence is executed in a 10 L jacketed glass reactor with recirculating chiller capable of maintaining a set point of -25 °C during the mixed-anhydride formation; batch-to-batch variance in anhydride formation was reduced by 18% after switching from manual dropwise addition to a syringe pump delivering the chloroformate at a controlled rate of 2.5 mL/min.

    Manufacture of a key fragment for macrocyclic HCV protease inhibitors proceeds via a linear sequence in which the Boc-protected 5-methylproline is condensed with a cyclopropyl-containing amino acid ester. The coupling is performed using 1.05 equivalents of 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU) and 2.2 equivalents of N,N-diisopropylethylamine in dimethylformamide at 0–5 °C for 1 h. Under these conditions, the epimerisation level, determined by a parallel Anderson racemisation test employing isotopically labelled 13C at the α-carbon, is held below 0.3%. After aqueous work-up with 10% citric acid and back-extraction with ethyl acetate, the organic layer is dried over sodium sulfate and concentrated under reduced pressure below 40 °C bath temperature to avoid premature Boc loss; the crude dipeptide is taken forward without chromatography, relying on a solvent swap to methyl tert-butyl ether and seeding with authentic crystalline material to induce crystallisation and upgrade the diastereomeric purity from 98.2% to 99.7% in a single recrystallisation. A 20 L rotary evaporator with a vacuum controller set to 50 mbar is used for solvent stripping; foaming is suppressed by maintaining a rotation speed of 80 rpm and gradually increasing vacuum from 200 mbar to the target over 15 min.

    When Boc is removed prior to organocatalytic activation, what solvent matrix preserves catalyst configuration?

    The free (2S,5S)-5-methylpyrrolidine-2-carboxylic acid, obtained after Boc deprotection with 4 M HCl in dioxane at room temperature for 2 h, functions as an effective enamine catalyst for asymmetric aldol reactions between cyclic ketones and aromatic aldehydes. The catalytic activity hinges entirely on the in situ formation of a (Z)-enamine that transfers stereochemical information through a chair-like transition state. Catalyst loading as low as 3 mol% in dimethyl sulfoxide supplemented with 10% water at 25 °C furnishes the corresponding β-hydroxy ketone with an anti:syn diastereomeric ratio of 92:8 and 88% enantiomeric excess for the anti isomer, as measured by chiral stationary-phase GC on a β-cyclodextrin column. When tetrahydrofuran is substituted for dimethyl sulfoxide, the diastereoselectivity drops to 82:18 and ee to 73%, underscoring the critical role of the polar aprotic environment in stabilising the iminium species. Catalyst degradation manifests as a yellow discoloration and a rise in pH above 7.5; activity is restored by the addition of 0.5 equivalents of 2,4-dinitrobenzoic acid as a cocatalyst, which accelerates enamine formation without eroding enantioselectivity. The scope is limited to aldehydes lacking acidic α-protons; attempts with phenylacetaldehyde give predominant self-aldol condensation, reducing the desired cross-aldol product yield to less than 15%, a boundary explicitly stated on the certificate of analysis when the compound is supplied for catalysis screening.

    The productivity bottleneck in organocatalytic applications emerges at the phase-transfer step after the reaction is quenched with aqueous ammonium chloride. The methylated proline catalyst, being freely soluble in water, requires continuous extraction with ethyl acetate over 12 h to achieve recovery above 90%. In a pilot-scale campaign for a neuroactive β-hydroxy ketone intermediate, the post-reaction stream was processed in a mixer-settler unit with a dwell time of 8 min per stage; three theoretical stages gave a catalyst recovery of 94.5%, monitored by quantitative 1H NMR integration of the pyrrolidine C-2 methine signal at 3.9 ppm. The recovered catalyst, after freeze-drying, retained 97% of its initial activity over five cycles when the residual water content after lyophilisation was kept below 0.8%. Above 1.2% water, the second-cycle ee decayed from 88% to 76%, attributable to non-stereoselective background catalysis by a hydrated iminium species.

    Eliminating tin residues after Boc cleavage: a validated protocol for GMP intermediates

    In routes that introduce the 5-methyl group via a cupric or stannous-mediated methyl transfer, the subsequent Boc protection and later deprotection generate an intermediate contaminated with organotin byproducts that must be reduced to conform to ICH Q3D inhalation and parenteral limits of 6 µg/day for tin. A dedicated purification sequence is inserted immediately after the acidic Boc removal with 35% hydrochloric acid in ethyl acetate. The resulting hydrochloride salt is dissolved in deionised water and treated with 1.2 equivalents of dimercapto-1,3,4-thiadiazole (DMTD) complexed on macroporous polystyrene resin, stirring at 50 °C for 4 h. The slurry is filtered hot through a 0.45 µm PTFE membrane, and the filtrate is analysed by inductively coupled plasma mass spectrometry; typical tin levels fall from 250 ppm to 4 ppm after a single treatment. The regulatory dossier for a Phase II candidate included a justification for the 6.5× safety margin relative to the PDE, supported by a full mass balance demonstrating that tin residuals partition exclusively into the aqueous mother liquor after crystallisation of the zwitterionic amino acid at its isoelectric point (pH 5.9). The crystallisation vessel, a 50 L Hastelloy reactor with polished surface finish Ra ≤ 0.8 µm, is cooled from 45 °C to 0 °C at a rate of 0.1 °C/min to generate crystals of median particle size 120 µm; rapid cooling consistently entrains tin-rich inclusions, detected as grey specks under polarised light microscopy.

    How (2S,5S)-5-methylpyrrolidine insertion alters backbone dihedral angles and protease recognition

    The replacement of a native L-proline with (2S,5S)-5-methylproline in glucagon-like peptide-1 (GLP-1) receptor agonist analogues imposes a predictable conformational restriction: the methyl substituent biases the pyrrolidine ring toward a Cγ-exo pucker, which widens the φ dihedral angle by approximately 8–12° and stabilises the trans amide bond with an equilibrium constant increased from 4.5 to 7.8 (measured by 13C NMR integration of Pro Cβ/Cγ signals in D2O at pH 4.5). This shift shields the peptide backbone from dipeptidyl peptidase-IV (DPP-IV) cleavage, extending the half-life in rat plasma from 2.1 h to 7.5 h as determined by LC-MS/MS monitoring of the intact N-terminal octapeptide. The Boc-protected amino acid is incorporated using standard Fmoc solid-phase peptide synthesis protocols on a Rink Amide MBHA resin, with 3.0 eq of the building block, 3.0 eq of 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), and 6.0 eq of N,N-diisopropylethylamine in N-methyl-2-pyrrolidone. Double coupling of 45 min each is mandatory because the steric hindrance of the tertiary Boc-protected amine reduces the Kaiser test negativity threshold after a single coupling to a residual free amine content of 1.8%, which falls to 0.2% after the second cycle. The Boc group is then removed on-resin with 30% trifluoroacetic acid in dichloromethane for 2 × 30 min, followed by neutralisation with 5% diisopropylethylamine before chain elongation; premature TFA exposure of later acid-sensitive side-chain protecting groups (such as the trityl group on histidine) is prevented by inserting a Dde-protected linker orthogonal to the temporary Boc strategy. The finished peptide is cleaved with 95% trifluoroacetic acid, 2.5% water, and 2.5% triisopropylsilane, precipitated from cold diethyl ether, and purified by preparative reverse-phase HPLC on a C18 column eluting with a gradient of acetonitrile in 0.1% aqueous trifluoroacetic acid, where the target analogue elutes at 33.7 min compared to 31.2 min for the des-methyl impurity, enabling a fraction collection cut-point that maintains >99.0% purity as verified by UPLC with photodiode array detection.

    In the metabolic stability assessment, the (2S,5S)-5-methylproline-containing peptide was compared head-to-head with the all‑L-proline parent in a simulated intestinal fluid screen (FaSSIF, biorelevant medium at pH 6.5 and 37 °C). The parent peptide showed 48% degradation within 60 min, whereas the methylated analogue remained 94% intact, a difference attributed entirely to the steric occlusion of the scissile amide bond as probed by molecular dynamics simulations that revealed a reduced solvent-accessible surface area at the carbonyl oxygen by 25 Å2. This behaviour is exploited in the development of once-weekly injectable formulations where the peptide is conjugated to a fatty acid chain via a γ-glutamate spacer; the conjugation is performed in solution after resin cleavage and global deprotection, using the free N-terminal amine exposed after Boc removal, and the acylation with octadecanedioic acid mono-tert-butyl ester is driven to completion with 1.1 eq of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide and 0.5 eq of 1-hydroxybenzotriazole in 90% DMF/water at pH 5.5 for 18 h, conditions under which the 5-methylproline amide bond remains stable with less than 0.5% observed diketopiperazine formation at the Pro-adjacent site.

    Coupling methodEquiv. of Boc-(2S,5S)-5-methylProReaction time (min)Residual free amine (%)Unwanted D-epimer (%)
    HBTU/DIEA single coupling3.0451.80.4
    HBTU/DIEA double coupling3.0 × 245 + 450.20.3
    HATU/DIEA single coupling2.5300.9<0.2
    COMU/Oxyma single coupling2.5600.3<0.2

    SPPS coupling efficiency comparison for Boc-(2S,5S)-5-methylproline on Rink Amide MBHA resin; residual amine quantified by Fmoc deprotection UV at 301 nm against a glycine standard, D-epimer determined by HPLC after resin cleavage and Marfey's derivatisation with 1-fluoro-2,4-dinitrophenyl-5-L-alanine amide.

    Process-scale diastereomeric enrichment via crystallisation-driven resolution

    When the preceding synthetic sequence delivers the Boc-protected acid with a diastereomeric ratio as low as 85:15 (resulting from incomplete stereocontrol during 5-methyl group installation), a thermodynamically controlled crystallisation is implemented in the final step. The crude mixture is dissolved in isopropanol at 60 °C to a concentration of 250 g/L and cooled to 5 °C over 12 h with seeding of authentic (2S,5S) crystals at 45 °C. The crystalliser, a baffled 200 L glass-lined vessel with retreat-curve impeller, is operated at 35 rpm; the metastable zone width for the desired enantiomer was measured at 7.3 °C by focused beam reflectance measurement, permitting a cooling profile that keeps the supersaturation ratio below 1.15 and avoids spontaneous nucleation of the (2R,5R) isomer. The first crop yields crystals of 99.1% de with 62% recovery; the mother liquor, enriched in the undesired isomer, is concentrated and subjected to epimerisation at the C-2 position with 0.1 eq of DBU in refluxing toluene for 8 h, re-equilibrating to near 1:1 and allowing a second recovery cycle after Boc re-protection. A mass balance accounting for solvent incineration costs established that the overall process yield from racemic starting material reaches 48% after two resolution-epimerisation loops, a value that justifies the use of the chiral building block in commercial peptide active pharmaceutical ingredient manufacture under a generic Drug Master File. Residual isopropanol in the final dried cake is controlled to 5000 ppm to meet ICH Q3C Class 3 limits, necessitating a final drying phase at 45 °C under 10 mbar for 24 h with intermittent nitrogen sweeping.

    Direct comparison of solution-phase epimerisation tendencies during peptide coupling between the HATU and IBCF activation modes, conducted at 0 °C in DMF, reveals that the mixed anhydride route generates 1.1% of the (2R,5S) diastereomer as measured by a validated achiral-impurity HPLC method using a Zorbax SB-C8 column, while the HATU route yields 0.2%. This difference, although small, becomes commercially significant at the multi-kilogram scale when the target product must meet a specification of NMT 0.5% of any single unspecified impurity, a common requirement in USP <1086> for peptide drug substances. The acyl chloride approach, tested for completeness, resulted in 6.3% epimerisation and was abandoned during early process development.

    ImpurityRRT (HPLC)Acceptance criterion (%)Batch A result (%)Batch B result (%)
    (2R,5R) enantiomer1.220.30.120.09
    (2R,5S) epimer0.870.50.310.28
    Des-methyl analogue0.730.150.050.07
    Residual tin10 ppm3.8 ppm4.2 ppm

    Typical release specification for Boc-(2S,5S)-5-methylproline intended for GMP peptide synthesis; analysis performed according to Ph. Eur. 2.2.29 liquid chromatography and ICH Q3D elemental impurities.

    Free Quote

    Competitive (2S,5S)-1-(Tert-Butoxycarbonyl)-5-Methyl Pyrrolidine-2-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Designated by its IUPAC identity as (2S,5S)-1-(tert-butoxycarbonyl)-5-methylpyrrolidine-2-carboxylic acid, this chiral N-protected proline analogue is supplied as a white to off-white crystalline powder with a molecular formula C11H19NO4 and a molecular weight of 229.27 g mol⁻¹. The batch-to-batch purity specification requires ≥ 98% by reverse-phase HPLC (C18 column, gradient 5–95% acetonitrile in water with 0.1% trifluoroacetic acid, UV detection at 210 nm), while enantiomeric excess is controlled at ≥ 99.5% via chiral stationary-phase chromatography (Chiralpak IA, hexane:isopropanol 90:10 with 0.1% TFA, flow rate 1.0 mL min⁻¹). The compound is employed almost exclusively as a sterically demanding building block in solution- and solid-phase peptide synthesis, where the cis relationship between the C2 carboxylic acid and the C5 methyl substituent imposes a conformational lock that departs sharply from unsubstituted Boc-Pro-OH. Immediate end-use handling requires anhydrous conditions: upon opening, the powder adsorbs atmospheric moisture reversibly, with Karl Fischer titration indicating 1.8 wt% water uptake within 6 h at 50% relative humidity and 23 °C. Storage in vacuum-sealed, argon-flushed foil pouches at −20 °C maintains specification integrity for a shelf life of 24 months from the date of manufacture.

    How Does the (2S,5S) Configuration Influence Conformational Rigidity?

    The (2S,5S) absolute configuration places the carboxyl and the methyl group on the same face of the pyrrolidine ring, defining a cis substitution pattern. X-ray crystallographic data for related 5-substituted proline derivatives deposited in the Cambridge Structural Database indicate that the ring adopts a 3E envelope conformation in which the C5 methyl orients pseudoaxially to minimize 1,3-allylic strain with the N-Boc carbonyl group. This spatial arrangement blocks the approach trajectory of activated amino acid esters to the nitrogen lone pair, leading to a measurable increase in the activation energy of amide bond formation. In practical terms, the steric shielding of the secondary amine becomes the rate-limiting factor in coupling protocols. Comparative kinetic monitoring of coupling reactions using Fmoc-Ala-OH (activation with HATU and DIPEA in DMF at 0.1 M) on an automated peptide synthesizer showed that the (2S,5S) diastereomer requires a pre-activation time of 5–7 min before resin addition to prevent a steep drop in instantaneous coupling efficiency, whereas the corresponding (2S,5R)-trans isomer reaches full activation within 2 min under identical conditions. The constrained geometry also exerts a secondary effect on the piperidine-mediated Fmoc deprotection: the N-terminal Boc group shields the pyrrolidine nitrogen, requiring 2 × 5 min treatments with 20% piperidine in DMF rather than the standard 2 × 2 min cycle for unsubstituted Boc-Pro residues, a phenomenon tracked by the persistence of the dibenzofulvene-piperidine adduct UV signal at 304 nm.

    Coupling Efficiency Under Standard Solid-Phase Protocols

    When this monomer is incorporated into a growing peptide chain on a low-loading Wang resin (substitution level 0.28–0.35 mmol g⁻¹), the steric compression imposed by the cis-5-methyl group dramatically reduces the coupling velocity compared to Boc-Pro-OH. Process development runs on a CEM Liberty Blue microwave synthesizer at 50 °C with 3 equiv. of incoming Fmoc-amino acid and 2.9 equiv. of HATU in DMF reveal that single couplings of 30 min achieve 99% yield for Boc-Pro-OH at position i+1, while the (2S,5S) analogue yields only 61–68% under the same conditions. A double-coupling protocol ( 2 × 60 min) is mandatory to reach acceptable completion (>99% by Kaiser test). The steric penalty is particularly pronounced with β-branched amino acids: Fmoc-Ile-OH requires 3 × 90 min couplings with 4 equiv. of the incoming amino acid and 3.9 equiv. of PyBOP to limit deletion sequences to <2.0%. Furthermore, microwave-assisted protocols at 90 °C exacerbate epimerization; analysis of the crude linear pentapeptide by ion-pairing HPLC (C8 column, triethylammonium phosphate buffer) detects 4.3% D-epimer at the penultimate position when the (2S,5S) building block is coupled with HATU/DIPEA at high temperature, versus 0.8% for Boc-Pro-OH. Consequently, a manufacturer-recommended coupling protocol specifies a ceiling temperature of 50 °C with HOAt/DIC activation in NMP, which reduces epimer content to ≤0.5% while maintaining complete coupling within 3 h.

    Resin washing and swelling characteristics also diverge from the standard profile. During synthesis on Rink amide AM resin, the bulky Boc-5-methylproline residue causes a slight shrinkage of the polymer matrix after coupling, reducing solvent uptake and temporarily lowering the estimated resin swelling by 8–12% in DMF, as measured by volumetric expansion in a fritted syringe. This effect is fully reversed upon Fmoc removal, but if undetected, it can lead to channeling during flow-through washing steps on a Tribute peptide synthesizer, producing uneven reagent contact in the column reactor. Operators routinely address this by incorporating an additional 15 s nitrogen-bubble agitation step after draining the deprotection cocktail.

    Diketopiperazine Suppression and Cleavage from Acid-Labile Resins

    One divergent property of the (2S,5S) scaffold is its pronounced resistance to diketopiperazine (DKP) formation upon mild acidic cleavage. When dipeptides containing Boc-5-methylproline at the C-terminus are cleaved from 2-chlorotrityl chloride resin using 1% TFA in dichloromethane, DKP by-product remains below 1.5% by LC-MS after 30 min exposure, compared to 8–12% for the sterically unrestricted Boc-Pro dipeptides. The cis-5-methyl group restricts the rotation around the ψ dihedral angle necessary to align the N-terminal amine and the resin ester for cyclative release. This characteristic is advantageous in the synthesis of C-terminal proline-modified peptide acids where the fully protected peptide must remain intact during selective deprotection. In a head-to-head comparison on the same batch of H-Pro-2-ClTrt resin (loading 0.81 mmol g⁻¹), coupling Fmoc-Leu-OH to produce Fmoc-Leu-(2S,5S)-5-methylPro-2-ClTrt resin and subsequent treatment with 0.5% TFA/CH2Cl2 (5 × 2 min) afforded the protected dipeptide acid in 93% isolated yield after precipitation with cold diethyl ether, with DKP contamination <0.3%.

    Table 1: Comparative Reactivity Profile of Boc-5-Methylproline Stereoisomers in Model Coupling Reactionsa
    Stereoisomer Optical Rotation [α]D20 (c=1, MeOH) HPLC Rt (min)b Coupling Time to Fmoc-Val-OH (min)c Coupling Yield (%)d DKP After Cleavage (%)
    (2S,5S)-1-Boc-5-methylPro-OH −34 ± 2 8.9 2 × 60 88 1.2
    (2S,5R)-1-Boc-5-methylPro-OH −52 ± 2 8.1 45 96 4.6
    (2R,5R)-1-Boc-5-methylPro-OH +34 ± 2 8.9 2 × 60 88 1.3
    (2R,5S)-1-Boc-5-methylPro-OH +52 ± 2 8.1 45 95 4.7
    Boc-Pro-OH (unsubstituted) −60 ± 2 7.5 25 99 8.5
    a Internal QC screening data generated on a CEM Liberty Blue synthesizer, H-Arg(Pbf)-Wang resin (0.32 mmol g⁻¹), coupling with 3 equiv. amino acid/2.9 equiv. HATU/6 equiv. DIPEA in DMF at 50 °C. b RP-HPLC, Kinetex C18 5 μm, 4.6×150 mm, 5–95% MeCN/H2O (0.1% TFA) over 15 min. c Duration required to reach >98% coupling by Kaiser test. d Isolated yield of HPLC-purified dipeptide based on resin loading.

    Thermal Stability and Long-Term Storage Degradation Pathways

    Differential scanning calorimetry reveals a sharp melting endotherm with an onset at 139 °C (peak 142 °C) and an exothermic decomposition event beginning at 178 °C, corresponding to Boc-group thermolysis with release of isobutylene and carbon dioxide. Thermogravimetric analysis at 10 °C min⁻¹ under nitrogen shows a 0.3% mass loss up to 100 °C attributable to surface moisture and a stepwise loss of 41.2% between 178 °C and 230 °C, consistent with decarboxylation and volatilization. In accelerated stability chambers, sealed vials exposed to 40 °C/75% RH for 6 months exhibit 2.4% degradation, predominantly the free amino acid hydrochloride salt (confirmed by 1H NMR disappearance of the Boc singlet at 1.45 ppm and appearance of a downfield NH2 signal) and trace diketopiperazine (<0.1%). The degradation rate accelerates below pH 3 and above pH 8 in aqueous/organic mixtures, which precludes any prolonged handling in acidic cleavage cocktails beyond those established for resin cleavage. For peptide synthesis laboratories, it is recommended that once a stock solution in anhydrous DMF ( 0.1 M) is prepared, it be used within 24 h when stored at 4 °C, as residual free amine begins to accumulate after this window due to trace HCl-induced deprotection, detectable by ESI-MS as an ion at m/z 130.1 [M+H]+.

    During large-scale peptide manufacture on a 50 mmol scale, a critical processing bottleneck emerged during the coupling of (2S,5S)-Boc-5-methylproline as the final residue in a heptapeptide sequence. The dissolved monomer solution, after being held for 36 h in an in-line syringe pump at ambient temperature due to a scheduling delay, had partially deprotected, leading to uncontrolled double incorporation of the building block into the sequence and a final crude purity of only 62% by UPLC, versus the expected 85%. This event triggered a change order mandating that all coupling solutions be prepared fresh within 6 h of scheduled use and that in-line conductivity monitoring of the DIPEA hydrochloride by-product be used to confirm complete acylation before proceeding to capping.

    When This Building Block Replaces Boc-Proline in Macrocyclic Peptide Synthesis

    The introduction of a cis-5-methyl substituent into a linear peptide precursor that subsequently undergoes cyclization imposes a measurable effect on ring-closure kinetics. In a model hexapeptide sequence cyclized via an amide bond between an N-terminal glycine and a C-terminal (2S,5S)-5-methylproline activated with HATU/DIEA under dilute conditions ( 1 mM in DMF), the isolated yield of the 18-membered macrocycle increased from 12% (using Boc-Pro) to 28%. The improvement is attributed to the reduction of backbone conformational entropy by the cis-methyl lock, which populates conformers already predisposed to end-to-end contact. The same substitution simultaneously retards the intermolecular oligomerization pathway, as indicated by a doubling of the critical cyclization concentration (from 5 mM to 10 mM). This property has been exploited in the synthesis of sterically shielded peptidomimetic inhibitors of proteasome activity, where the 5-methyl group additionally protects the adjacent scissile amide bond from premature hydrolysis, extending the half-life in rat plasma from <10 min to 38 min for a selected cyclic tripeptide core.

    Liquid Chromatography–Mass Spectrometry Fingerprint and Identity Confirmation

    For incoming quality control, five orthogonal analytical methods are applied to confirm identity and purity. The intact mass confirmed by direct infusion Q-TOF MS yields a protonated molecular ion at m/z 230.1392 ([M+H]+, Δ 0.8 ppm). 1H NMR ( 400 MHz, DMSO-d6) displays a characteristic doublet for the C5 methyl group at 1.16 ppm (J = 6.4 Hz), the Boc tert-butyl singlet at 1.37 ppm, and a broad singlet for the carboxylic acid proton at 12.35 ppm. On a chiral HPLC screen, the (2S,5R) trans isomer elutes at 6.2 min under conditions that retain the (2S,5S) isomer until 8.0 min, providing baseline separation (resolution >2.0). Heavy metal screen by ICP-MS after microwave digestion consistently returns values <10 ppm for lead, cadmium, and mercury. Residual solvent analysis by headspace GC-FID (Ph. Eur. 2.4.24) quantifies dichloromethane at <600 ppm and methanol at <3000 ppm, well within ICH Q3C limits for a reagent intended for early-phase API synthesis.

    Table 2: In-House Certificate of Analysis — Acceptance Criteria Matrix
    Test Parameter Analytical Procedure Acceptance Limits
    Appearance (visual) Ph. Eur. 2.2.1 White to off-white crystalline powder
    Purity (HPLC) In-house SOP LC-014, C18 220 nm 98.0% area
    Enantiomeric purity (chiral HPLC) Chiralpak IA, hexane:IPA 90:10 + 0.1% TFA 99.5% ee
    Water content (KF coulometry) Ph. Eur. 2.5.12 0.5%
    Optical rotation [α]D20 Ph. Eur. 2.2.7, c=1 MeOH −32° to −36°
    Heavy metals (ICP-MS) Ph. Eur. 2.4.20, microwave digestion 10 ppm each for Pb, Cd, Hg
    Residual solvents (GC-HS) Ph. Eur. 2.4.24 MeOH ≤ 3000 ppm, CH2Cl2600 ppm